Prediction of response and survival in patients with chronic-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate: logistic regression and landmark analyses

Prediction of response and survival in patients with chronic-phase chronic myeloid leukemia treated with omacetaxine mepesuccinate: logistic regression and landmark analyses

Bibliographic Details
Main Authors: Wetzler, M, Kantarjian, H M, Nicolini, F E, Lipton, J H, Akard, L, Baccarani, M, Khoury, H J, Li, E, Munteanu, M, Cortes, J
Format: Online
Language:English
Published: Nature Publishing Group 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735071/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4735071/

Similar Items